Learning
is a dynamic process facilitated by the vibrant exchange of
knowledge and ideas. Conferences, seminars and symposia provide
an excellent opportunity to explore, discover and debate the
vast plethora of ideas and novel achievements in several areas
of interest. Integration of bioengineering and basic sciences
has led to significant advances in biomedical sciences. It
has provided both, new perspectives and powerful tools, which
have enriched medical research.
Biopharmaceuticals are defined as pharmaceuticals manufactured
by biotechnology methods, with the products having biological
sources, usually involving live organisms or their active
components. This includes all recombinant proteins, monoclonal
antibodies, vaccines, blood/plasma-derived products, non -recombinant
culture-derived proteins, and cultured cells and tissues.
The pharmaceutical industry has transformed itself into the
biopharmaceutical industry as a result of the "convergence"
of biotechnology and pharmaceutical technologies. The pharmaceutical
industry, through adoption of new technologies and close relationships
with biotech companies, has undergone a fundamental change
resulting in new, revolutionary technologies. Biopharmaceuticals
are no longer a subset of pharmaceuticals, with biopharmaceuticals
now taking in all pharmaceutical and biotechnology companies,
with a health care orientation.
The health care industry is one of the world's largest and
fastest-growing industries. Combining medical technology and
the human touch, the healthcare industry diagnoses, treats,
and administers care around the clock, responding to the immediate
needs and requirements. The delivery of health care services
is the most visible part of any health care system, both to
users and the general public. Improving access, coverage and
quality of health services depends on how the services are
organized and managed, and on the incentives influencing providers
and users. Healthcare is literally of vital importance, and
requires understanding of ethical and social as well as financial
issues; yet healthcare is in great need of sensible economic
policies to achieve value for money.
This congregation attempts to gather the leaders and stakeholders
of these progressive fields, including venture capitalists,
scientists, academicians, researchers, students and most importantly,
the general public. The platform aims to update, discuss,
network and exchange stimulating ideas on the most recent
achievements in the different topics of Biopharmaceuticals
& Healthcare. Through this conference we hope to achieve
closer links/collaboration between scientists and engineers.
We also aim at educating the general public and taking the
fruits of research from lab level and realizing their potential
benefits to society. |
